JN.1 most common COVID variant in US by Dec 23?
JN.1 most common COVID variant in US by Dec 23?
$3,923 Vol.
$3,923 Vol.
Dec 23, 2023
$3,923 Vol.
$3,923 Vol.
Dec 23, 2023
This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
생성일: Dec 19, 2023, 12:57 PM ET
볼륨
$3,923종료일
Dec 23, 2023생성일
Dec 19, 2023, 12:57 PM ETResolution Source
https://covid.cdc.gov/covid-data-tracker/#variant-proportionsResolver
0x6A9D22261...제안된 결과: Yes
이의 없음
최종 결과: Yes
This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
볼륨
$3,923종료일
Dec 23, 2023생성일
Dec 19, 2023, 12:57 PM ETResolution Source
https://covid.cdc.gov/covid-data-tracker/#variant-proportionsResolver
0x6A9D22261...제안된 결과: Yes
이의 없음
최종 결과: Yes

외부 링크를 조심하십시오.
외부 링크를 조심하십시오.
Frequently Asked Questions